Anti-CSF2Rb/CD131 Antibody (CSL311)
Catalog No.
F1636
Anti-CSF2Rb/CD131 Antibody (CSL311)
Featured Products
Trabikibart (CSL311) is a βc-specific, fully human monoclonal antibody that binds to a unique epitope specific for the cytokine binding site of the human βc receptor with picomolar binding affinity to the human βc receptor. Trabikibart is a potent inhibitor of the combined effects of IL-3, GM-CSF, and IL-5 on eosinophil survival. Trabikibart has the potential to be used in chronic inflammatory diseases.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.66 kDa
Dry ice
2643974-98-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CSL311
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P32927
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CSF2RB His at 2 ug/mL can bind Anti-CSF2Rb/CD131 Antibody (CSL311)
CSF2Rb / CD131
Please avoid freeze-thaw cycles.